within Pharmacolibrary.Drugs.V_Various.V09A_CentralNervousSystem.V09AX05_Florbetapir18f;

model Florbetapir18f
  extends Pharmacolibrary.Drugs.ATC.V.V09AX05;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>V09AX05</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Florbetapir (18F) is a radioactive diagnostic agent, a fluorine-18 labeled PET radiotracer used in positron emission tomography (PET) imaging of the brain to estimate beta-amyloid neuritic plaque density in adult patients being evaluated for Alzheimer’s disease and other causes of cognitive decline. It is FDA approved for clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for healthy adult subjects, both male and female, typical for adults undergoing amyloid PET imaging.</p><h4>References</h4><ol><li><p>Lowe, SL, et al., &amp; Sims, JR (2021). Donanemab (LY3002813) Phase 1b Study in Alzheimer&#x27;s Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging. <i>The journal of prevention of Alzheimer&#x27;s disease</i> 8(4) 414–424. DOI:<a href=&quot;https://doi.org/10.14283/jpad.2021.56&quot;>10.14283/jpad.2021.56</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34585215/&quot;>https://pubmed.ncbi.nlm.nih.gov/34585215</a></p></li><li><p>Sundaram, GSM, et al., &amp; Sharma, V (2020). Fluselenamyl: Evaluation of radiation dosimetry in mice and pharmacokinetics in brains of non-human primate. <i>Nuclear medicine and biology</i> 82-83 33–40. DOI:<a href=&quot;https://doi.org/10.1016/j.nucmedbio.2019.10.004&quot;>10.1016/j.nucmedbio.2019.10.004</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31891882/&quot;>https://pubmed.ncbi.nlm.nih.gov/31891882</a></p></li><li><p>Siemers, E, et al., &amp; Barton, R (2023). ACU193, a Monoclonal Antibody that Selectively Binds Soluble Aß Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development Plan. <i>The journal of prevention of Alzheimer&#x27;s disease</i> 10(1) 19–24. DOI:<a href=&quot;https://doi.org/10.14283/jpad.2022.93&quot;>10.14283/jpad.2022.93</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36641606/&quot;>https://pubmed.ncbi.nlm.nih.gov/36641606</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Florbetapir18f;
